Skip to main content

Table 6 Survival subgroups defined by survival in each treatment arm

From: Cytokine network analysis of immune responses before and after autologous dendritic cell and tumor cell vaccine immunotherapies in a randomized trial

TCV survival groups (n = 22)TC lowTCV intermediateTCV high
Number of cases985
Median overall survival (months)93160
DCV survival groups (n = 17)DCV lowDCV intermediateDCV high
Number of cases665
Median overall survival (months)154360
  1. TCV tumor cell vaccine, DCV dendritic cell vaccine